Q&A: Lynn Bry on Why a Clinically Annotated Database of Variants is Needed for Diagnostic Sequencing
July 06, 2011
Q&A: Lynn Bry on Why a Clinically Annotated Database of Variants is Needed for Diagnostic Sequencing
At an FDA workshop last month, Lynn Bry spoke in a panel session about the need for a clinically annotated database of variants, detailing how Partners HealthCare Center for Personalized Medicine had developed such a database that is using for its sequencing-based diagnostic tests.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Sequenom Ramps up Hiring, Licenses Additional Technology as it Nears Launch of T21 Test
August 9, 2011 / Clinical Sequencing News - People in the News
August 9, 2011 / Clinical Sequencing News - FDA Mulls Options for Regulating Next-Gen Sequencing Platforms in Clinical Diagnostics
June 29, 2011 / Clinical Sequencing News - Dutch Study Aims to Demonstrate Cost-Effectiveness of Reimbursing for Exome Sequencing Dx
October 19, 2011 / Clinical Sequencing News - Swedish Project Will Sequence Tumor Exomes to Study Drug Resistance, Develop Companion Tests
August 31, 2011 / Clinical Sequencing News